Charles River Laboratories CRL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $198.2M-8.2% | $216M+3.2% | $209.22M+13.3% | $184.74M-20.3% | $231.73M+12.7% | ||
| $1.93M+23.6% | $1.56M+172% | $573K+44.0% | $398K-56.0% | $904K— | ||
| $708.37M-1.5% | $719.32M-3.9% | $748.29M-4.1% | $780.41M+1.0% | $772.89M+4.6% | ||
| $359.72M+20.3% | $299.1M-1.1% | $302.55M+8.2% | $279.55M-3.7% | $290.16M+4.2% | ||
| $30.94M-24.5% | $40.96M+4.2% | $39.31M-6.0% | $41.82M-1.0% | $42.23M-1.9% | ||
| $53.34M-39.9% | $88.74M+36.3% | $65.1M+55.1% | $41.98M-24.4% | $55.54M+7.3% | ||
| $275.45M+62.6% | $169.4M-14.5% | $198.14M+1.2% | $195.75M+1.8% | $192.39M+4.7% | ||
| $134.86M+4.4% | $129.21M-22.4% | $166.44M+28.1% | $129.92M+29.6% | $100.23M-5.3% | ||
| $125.24M+4.5% | $119.9M-24.1% | $157.95M+31.7% | $119.96M+33.0% | $90.18M+8.7% | ||
| $288.26M+1,258% | $21.22M— | —— | —— | —— | ||
| $1.49B+2.9% | $1.45B-5.6% | $1.53B+4.2% | $1.47B-2.4% | $1.51B+7.4% | ||
| $1.51B-8.8% | $1.66B+4.0% | $1.59B-0.9% | $1.61B+1.2% | $1.59B-1.1% | ||
| $1.43B-6.9% | $1.54B+2.8% | $1.5B0.0% | $1.5B+2.3% | $1.46B+0.6% | ||
| $317.84M-12.1% | $361.42M-3.4% | $374.27M-3.0% | $385.76M-4.3% | $402.91M-2.3% | ||
| $3.04B+10.0% | $2.76B-5.4% | $2.92B-0.5% | $2.94B+2.2% | $2.87B+0.9% | ||
| $248.99M-26.8% | $340M-40.5% | $571.09M-5.2% | $602.45M-8.1% | $655.71M-9.4% | ||
| $81.4M-14.5% | $95.2M-22.6% | $123.01M+12.6% | $109.27M+1.9% | $107.27M+0.3% | ||
| $28.68M-8.0% | $31.18M-89.3% | $290.89M-1.9% | $296.46M+0.8% | $294.1M+5.7% | ||
| $209.72M+1.3% | $206.97M+6.3% | $194.64M-9.9% | $216.07M+1.0% | $214.03M-2.0% | ||
| $7.73B+8.3% | $7.14B-5.0% | $7.51B-0.6% | $7.56B-0.3% | $7.58B+0.7% | ||
| $133.95M-10.0% | $148.8M-12.3% | $169.62M+16.3% | $145.8M-2.4% | $149.33M+6.4% | ||
| $166.89M-37.9% | $268.85M-0.3% | $269.7M+18.5% | $227.51M+15.3% | $197.33M+10.0% | ||
| $194.33M-7.6% | $210.42M-11.5% | $237.73M-11.4% | $268.34M+7.1% | $250.46M+0.9% | ||
| $6.7M+3,936% | $166K+207% | $54K-44.9% | $98K-19.0% | $121K-21.9% | ||
| $1.59M-50.8% | $3.23M+25.0% | $2.58M-8.9% | $2.83M-15.4% | $3.35M+20.7% | ||
| $144.21M— | $0— | —— | —— | —— | ||
| $47.06M+3.1% | $45.63M+7.4% | $42.49M+12.8% | $37.67M+11.0% | $33.95M-1.0% | ||
| $48.74M+24.9% | $39.02M-29.5% | $55.37M+35.3% | $40.91M-1.2% | $41.41M+29.9% | ||
| $30.2M— | —— | $2.6M+8.3% | $2.4M+9.1% | $2.2M— | ||
| $1.09B-2.4% | $1.12B-0.1% | $1.12B+3.8% | $1.08B+2.8% | $1.05B+5.7% | ||
| $2.66B+24.7% | $2.14B-2.2% | $2.19B-6.3% | $2.33B-7.1% | $2.51B+12.1% | ||
| $393.11M-9.4% | $434.05M-2.1% | $443.19M-2.3% | $453.66M-4.5% | $475.11M-1.8% | ||
| $10.63M-61.9% | $27.88M-0.6% | $28.05M-1.7% | $28.55M-1.8% | $29.06M+2.2% | ||
| $10.63M-56.9% | $24.65M-12.1% | $28.05M-1.7% | $28.55M-1.8% | $29.06M+13.2% | ||
| $510.65M+269% | $138.3M-27.0% | $189.46M+2.3% | $185.21M-5.7% | $196.4M+0.6% | ||
| $30M0.0% | $30M-99.3% | $4.06B-2.4% | $4.16B-4.1% | $4.34B+8.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 120M0.0% | 120M0.0% | 120M0.0% | 120M0.0% | 120M+23,383% | ||
| $1.97B+1.0% | $1.95B-3.4% | $2.02B+1.2% | $1.99B+0.7% | $1.98B+0.6% | ||
| $1.37B-1.1% | $1.39B-28.6% | $1.94B+2.9% | $1.89B+2.8% | $1.84B+1.4% | ||
| -$191.04M-11.2% | -$171.78M+10.4% | -$191.62M-15.1% | -$166.47M+37.2% | -$265.25M+16.4% | ||
| $209.99M— | $0-100% | $363.43M0.0% | $363.34M+1.9% | $356.55M— | ||
| $41.9M+1.5% | $41.26M+1.9% | $40.49M+1.3% | $39.96M-4.1% | $41.66M+1.3% | ||
| $5.82M+9.8% | $5.3M+8.7% | $4.88M-22.7% | $6.31M+9.1% | $5.78M+6.1% | ||
| $2.94B-7.1% | $3.16B-7.1% | $3.41B+1.6% | $3.35B+5.0% | $3.19B-7.7% | ||
| $7.73B+8.3% | $7.14B-5.0% | $7.51B-0.6% | $7.56B-0.3% | $7.58B+0.7% | ||
| $8.11M-22.5% | $10.46M-24.2% | $13.81M+7.5% | $12.84M-21.0% | $16.26M-11.2% | ||
| $8.11M-22.5% | $10.46M-24.2% | $13.81M+7.5% | $12.84M-21.0% | $16.26M-11.2% | ||
| $275.45M+62.6% | $169.4M-14.5% | $198.14M+1.2% | $195.75M+1.8% | $192.39M+4.7% | ||
| $30.94M-24.5% | $40.96M+4.2% | $39.31M-6.0% | $41.82M-1.0% | $42.23M-1.9% | ||
| $195.62M-2.5% | $200.59M-4.9% | $210.88M-2.0% | $215.23M-0.3% | $215.95M+1.9% | ||
| $826.17M+182% | $293.19M+0.8% | $290.89M-1.9% | $296.46M+0.8% | $294.1M+5.7% | ||
| $1.04B-30.8% | $1.5B-12.0% | $1.7B-0.6% | $1.71B+2.3% | $1.67B-1.3% | ||
| $317.84M-12.1% | $361.42M-3.4% | $374.27M-3.0% | $385.76M-4.3% | $402.91M-2.3% | ||
| $88.6M+31.6% | $67.33M+82.4% | $36.91M-21.4% | $46.94M-3.8% | $48.79M+15.7% | ||
| $248.99M-26.8% | $340M-40.5% | $571.09M-5.2% | $602.45M-8.1% | $655.71M-9.4% | ||
| $317.84M-12.1% | $361.42M-3.4% | $374.27M-3.0% | $385.76M-4.3% | $402.91M-2.3% | ||
| $826.17M+182% | $293.19M+0.8% | $290.89M-1.9% | $296.46M+0.8% | $294.1M+5.7% | ||
| $1.51B-8.8% | $1.66B+4.0% | $1.59B-0.9% | $1.61B+1.2% | $1.59B-1.1% | ||
| $2.94B-7.9% | $3.19B+3.4% | $3.09B-0.5% | $3.1B+1.8% | $3.05B-0.3% | ||
| $317.84M-12.1% | $361.42M-3.4% | $374.27M-3.0% | $385.76M-4.3% | $402.91M-2.3% | ||
| $826.17M+182% | $293.19M+0.8% | $290.89M-1.9% | $296.46M+0.8% | $294.1M+5.7% | ||
| $166.89M-37.9% | $268.85M-0.3% | $269.7M+18.5% | $227.51M+15.3% | $197.33M+10.0% | ||
| $47.06M+3.1% | $45.63M+7.4% | $42.49M+12.8% | $37.67M+11.0% | $33.95M-1.0% | ||
| $372.4M+37.9% | $270.09M+18.0% | $228.9M-1.2% | $231.57M-4.5% | $242.47M+4.5% | ||
| $22M0.0% | $22M— | —— | —— | —— | ||
| $48.74M+24.9% | $39.02M-29.5% | $55.37M+35.3% | $40.91M-1.2% | $41.41M+29.9% | ||
| $372.4M+37.9% | $270.09M+18.0% | $228.9M-1.2% | $231.57M-4.5% | $242.47M+4.5% | ||
| $166.89M-37.9% | $268.85M-0.3% | $269.7M+18.5% | $227.51M+15.3% | $197.33M+10.0% | ||
| $226.14M+1.8% | $222.16M+2.9% | $215.95M+4.2% | $207.22M-2.0% | $211.47M+9.0% | ||
| $8.29M+144% | $3.39M+28.8% | $2.64M-10.1% | $2.93M-15.5% | $3.47M+18.4% | ||
| $20.71M-10.0% | $23.01M+59.3% | $14.44M-15.4% | $17.06M-31.2% | $24.8M-2.2% | ||
| 4%-0.1% | 4.1%-0.1% | 4.1%0.0% | 4.1%-0.5% | 4.6%+0.1% | ||
| $47.06M+3.1% | $45.63M+7.4% | $42.49M+12.8% | $37.67M+11.0% | $33.95M-1.0% | ||
| -$11.62M+6.8% | -$12.47M+6.4% | -$13.32M+6.0% | -$14.16M+5.7% | -$15.01M+5.3% | ||
| $66.3M-3.1% | $68.44M— | —— | —— | —— | ||
| $2.66B+24.7% | $2.14B-2.2% | $2.19B-6.3% | $2.33B-7.1% | $2.51B+12.1% | ||
| $47.06M+3.1% | $45.63M+7.4% | $42.49M+12.8% | $37.67M+11.0% | $33.95M-1.0% | ||
| $3.07B+15.7% | $2.66B0.0% | $2.66B-5.6% | $2.81B-6.6% | $3.02B+7.4% | ||
| $158.1M— | —— | $29.4M+0.7% | $29.2M+7.0% | $27.3M— | ||
| $153.2M— | —— | $25M+3.3% | $24.2M+5.7% | $22.9M— | ||
| $32.7M— | —— | —— | —— | —— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 49.3M+0.3% | 49.2M-4.2% | 51.4M0.0% | 51.3M+0.3% | 51.2M+0.1% | ||
| 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $1.97B+1.0% | $1.95B-3.4% | $2.02B+1.2% | $1.99B+0.7% | $1.98B+0.6% | ||
| $493K+0.2% | $492K-4.3% | $514K+0.2% | $513K+0.2% | $512K+0.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 50%— | —— | 50%0.0% | 50%0.0% | 50%— | ||
| $201.57M+1,214% | $15.34M— | —— | —— | —— | ||
| $8.11M-22.5% | $10.46M-24.2% | $13.81M+7.5% | $12.84M-21.0% | $16.26M-11.2% | ||
| $8.11M-22.5% | $10.46M-24.2% | $13.81M+7.5% | $12.84M-21.0% | $16.26M-11.2% | ||
| $406.25M+199% | $135.65M— | —— | —— | —— | ||
| $56.48M-3.3% | $58.43M— | —— | —— | —— | ||
| $64.38M-2.9% | $66.32M— | —— | —— | —— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $120M0.0% | $120M0.0% | $120M0.0% | $120M0.0% | $120M0.0% | ||
| $49.34M+0.3% | $49.22M-4.2% | $51.35M0.0% | $51.34M+0.3% | $51.2M+0.1% | ||
| $48.17M-2.1% | $49.22M0.0% | $49.22M0.0% | $49.21M+0.2% | $49.12M-4.0% | ||
| $195.62M-2.5% | $200.59M-4.9% | $210.88M-2.0% | $215.23M-0.3% | $215.95M+1.9% | ||
| —— | $256M— | —— | —— | —— | ||
| $104.75M-1.7% | $106.6M+16.9% | $91.17M-1.5% | $92.58M-7.1% | $99.65M+11.4% | ||
| $44M+2.3% | $43M+26.5% | $34M0.0% | $34M-12.8% | $39M+2.6% | ||
| -$11.62M+6.8% | -$12.47M+6.4% | -$13.32M+6.0% | -$14.16M+5.7% | -$15.01M+5.3% | ||
| $0.04-2.5% | $0.04-1.5% | $0.04-0.5% | $0.04-10.0% | $0.05+2.5% | ||
| $81.4M-14.5% | $95.2M-22.6% | $123.01M+12.6% | $109.27M+1.9% | $107.27M+0.3% | ||
| $66.3M-3.1% | $68.44M— | —— | —— | —— | ||
| $2.84M— | —— | —— | —— | $0— | ||
| $209.72M+1.3% | $206.97M+6.3% | $194.64M-9.9% | $216.07M+1.0% | $214.03M-2.0% | ||
| $1.59M-50.8% | $3.23M+25.0% | $2.58M-8.9% | $2.83M-15.4% | $3.35M+20.7% | ||
| $787.84M-32.0% | $1.16B+2.3% | $1.13B+1.8% | $1.11B+9.1% | $1.02B+4.7% | ||
| $1.04B-30.8% | $1.5B-12.0% | $1.7B-0.6% | $1.71B+2.3% | $1.67B-1.3% | ||
| $3.04B+10.0% | $2.76B— | —— | —— | —— | ||
| $22M0.0% | $22M— | —— | —— | —— | ||
| $144.21M— | $0— | —— | —— | —— | ||
| $2.66B+24.7% | $2.14B-2.2% | $2.19B-6.3% | $2.33B-7.1% | $2.51B+12.1% | ||
| $8.29M+144% | $3.39M+28.8% | $2.64M-10.1% | $2.93M-15.5% | $3.47M+18.4% | ||
| $2.67B+24.5% | $2.15B-2.3% | $2.2B-6.3% | $2.35B-7.1% | $2.53B+12.0% | ||
| $2.68B+24.7% | $2.15B-2.2% | $2.2B-6.3% | $2.35B-7.1% | $2.53B+12.0% | ||
| $5.82M+9.8% | $5.3M+8.7% | $4.88M-22.7% | $6.31M+9.1% | $5.78M+6.1% | ||
| $1.51B-8.8% | $1.66B+4.0% | $1.59B-0.9% | $1.61B+1.2% | $1.59B-1.1% | ||
| $51.51M+479% | $8.89M— | —— | —— | —— | ||
| $36.99M-0.7% | $37.26M— | —— | —— | —— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $102.15M+6.3% | $96.11M-20.9% | $121.54M+10.5% | $110M-15.4% | $129.99M+25.9% | ||
| $41.9M+1.5% | $41.26M+1.9% | $40.49M+1.3% | $39.96M-4.1% | $41.66M+1.3% | ||
| $20.71M-10.0% | $23.01M+59.3% | $14.44M-15.4% | $17.06M-31.2% | $24.8M-2.2% | ||
| $702.2M— | —— | $649.3M-10.7% | $727.3M-7.0% | $781.9M— | ||
| $512.74M-1.2% | $518.73M-3.5% | $537.4M-4.9% | $565.18M+1.5% | $556.94M+5.5% | ||
| $1.18M— | $0-100% | $2.14M0.0% | $2.14M+2.4% | $2.09M— | ||
| $158.1M— | —— | $29.4M+0.7% | $29.2M+7.0% | $27.3M— | ||
| $30.2M— | —— | $2.6M+8.3% | $2.4M+9.1% | $2.2M— | ||
| $153.2M— | —— | $25M+3.3% | $24.2M+5.7% | $22.9M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Charles River Laboratories's total assets?
- Charles River Laboratories (CRL) holds $7.7B in total assets, up 1.9% year over year.
- How much debt does Charles River Laboratories have?
- Charles River Laboratories carries $3.1B in total debt against $2.9B of shareholders' equity, a debt-to-equity ratio of 1.05.
- How much cash does Charles River Laboratories have?
- Charles River Laboratories holds $198.2M in cash and equivalents.
- Can Charles River Laboratories cover its short-term obligations?
- Its current ratio is 1.36 — current assets exceed current liabilities.
- Where does Charles River Laboratories's balance sheet data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
